Entry and the number of firms in the Swedish pharmaceuticals market

Review of Industrial Organization

Volumn 19, Issue 3, 2001, Pages 351-364

  Rudholm, N ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Entry; Number of firms; Panel data; Pharmaceutical industry

Indexed keywords

INDUSTRIAL PERFORMANCE; PANEL DATA; PHARMACEUTICAL INDUSTRY; PROFITABILITY;

SWEDEN;

EID: 0034770799     PISSN: 0889938X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011868404205     Document Type: Article

References (18)

1. First-order integer valued autoregressive (INAR(1)) process
2. Effective patent life of drugs in Sweden - A comparison with international studies
3. Drug patent expirations and the speed of generic entry
4. Entry and exit of plants: A study based on Swedish panel count data
5. Explanatory variables in the AR(1) poisson model
6. Forecasting based on very small samples and additional non-sample information
7. Generalized integer-valued autoregression
8. Brand loyalty, entry and price competition in pharmaceuticals after the 1984 drug act
9. Pricing dynamics in the pharmaceutical industry
10. Some simple models for discrete variate time series
11. Entry decisions in the generic pharmaceutical industry
12. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity
13. Some determinants of entry into therapeutic drug markets